Artificial Intelligence
Provides additional data and decision support for egg, sperm and embryo assessment.
Using your age, menstrual and uterine status, previous treatment history and your egg and sperm source selections, see the recorded outcomes of the closest clinical patient group to you among patients previously treated at Ventus IVF.
This tool does not provide a personal pregnancy guarantee or medical diagnosis. The result shows clinical outcomes previously observed in the Ventus IVF patient group that most closely matches the information you provide. A definitive treatment plan is determined after examination, tests, embryological data and specialist assessment.
Before starting the calculation, review the cumulative outcomes of the broader IVF and donor groups in our clinical records.
This information is used to guide you to the appropriate clinical data group and is not stored outside your browser.
Uterine information does not mathematically change the percentages in this version; it generates clinical notes that should be considered during specialist assessment.
Treatment history is important when interpreting results. Because we do not have a separate reliable rate for every combination of these variables, we do not arbitrarily increase or decrease the numerical result.
This is one of the main selections that determines the treatment group.
Together with the egg source, this selection helps us identify the closest treatment group.
The result will show the closest clinical treatment group based on the information you provided. Your data are not sent to the server or stored.
Because your selections are close to a special clinical record group with an average female age of 48, we also show this data separately.
This calculator shows historical clinical outcomes for patient groups similar to you. Every patient is different and requires an individual treatment plan. Share your result with us via WhatsApp; our specialist team can review your situation and help you understand suitable treatment options and next steps.
Even if you are the same age as another patient, ovarian reserve, sperm factors, embryo history, uterine status and previous treatments may differ. A personalised treatment plan can only be created when all relevant information is assessed together.
Ventus IVF considers high cumulative clinical outcomes not as a percentage alone, but together with personalised treatment planning, embryology expertise, a controlled laboratory environment and technology-supported processes.
Provides additional data and decision support for egg, sperm and embryo assessment.
Supports continuous monitoring of embryo development through a time-lapse system.
Contributes to controlled management of laboratory air quality and environmental variables.
Supports systematic management of quality, traceability and laboratory processes.
Adds an identity-verification and traceability layer to gamete and embryo processes.
A rapid freezing approach used in cryopreservation of oocytes and embryos.
This tool is not a medical prediction model. It finds the closest match among groups for which we have actual clinical data.
Age, treatment history, uterine/menstrual status and gamete-source selections are collected.
The group is determined according to whether you select own eggs, donor oocytes, donor sperm or embryo donation.
Only data from a group for which Ventus IVF has recorded clinical outcomes are used.
Uterine factors, AMH, previous attempts and other factors are assessed separately during personalised treatment planning.
No. The result shows the clinical outcome previously observed in the Ventus IVF patient group that most closely matches the information you provide. Your individual outcome may differ according to examination, test results, embryological findings and treatment plan.
Your age and gamete-source selections are used to identify the closest recorded clinical group. Uterine status, menstrual status, AMH and previous-treatment information generate additional clinical notes for specialist assessment; in this version they do not arbitrarily increase or decrease the rate.
A cumulative outcome is a broader clinical assessment that may include not only the first transfer but also subsequent eligible transfers within the defined treatment journey.
Positive pregnancy and live birth are not the same clinical endpoint. Early pregnancy loss, chromosomal or embryological factors, maternal age and other medical factors during pregnancy can affect the outcome.
The current Ventus IVF success dataset does not contain sufficiently large, consistently defined separate rates for each uterine condition. Using this information to mathematically alter the rate would therefore be misleading. Instead, it is added as a note for specialist assessment.
IVF using a patient's own oocytes, egg donation, sperm donation and embryo donation have different biological starting conditions and patient profiles. It is therefore more meaningful to assess their clinical outcomes in separate groups.
Ventus IVF records include a separately monitored clinical group for oocyte and embryo donation in patients aged 45 and over. In this group, with an average female age of 48, cumulative positive pregnancy is 84.5% and cumulative live birth is 64%.
Yes. The WhatsApp button on the result screen converts your selections and the displayed clinical outcome summary into a prepared message. It is not sent automatically; once WhatsApp opens you can review, edit or delete any lines you do not want to share.
In this version, the calculator runs inside your browser. Your form selections are not sent to the server during the calculation and are not permanently stored by this tool.
No. This tool is intended for information and clinical-data matching. A treatment plan can only be created after specialist medical assessment, laboratory findings and personal medical information are reviewed together.
The calculator shows historical outcomes for patient groups similar to you. The next step is for your medical history and test results to be reviewed by Ventus IVF specialists.